High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
Orly Vardeny*, Jacob A. Udell, Jacob Joseph, Michael E. Farkouh, Adrian F. Hernandez, Alison J. McGeer, H. Keipp Talbot, Deepak L. Bhatt, Christopher P. Cannon, Shaun G. Goodman, Inder Anand, David L. DeMets, Jon Temte, Janet Wittes, Kristin Nichol, Clyde W. Yancy, J. Michael Gaziano, Lawton S. Cooper, Kyung Mann Kim, Scott D. Solomon
Dive into the research topics of 'High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial'. Together they form a unique fingerprint.